Supraglottic jet oxygenation and ventilation improves oxygenation during endoscopic retrograde cholangiopancreatography: a randomized controlled clinical trial.

Authors:
Su D; Zhang W; Li J; Tan X; Wei H and 2 more

Journal:
BMC Anesthesiol

Publication Year: 2024

DOI:
10.1186/s12871-024-02406-y

PMCID:
PMC10785419

PMID:
38216874

Journal Information

Full Title: BMC Anesthesiol

Abbreviation: BMC Anesthesiol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anesthesiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis clinical study was approved by the Institutional Review Board and Ethics Committee of Affiliated East Hospital of Tongji University (2021, No.097), Shanghai, China (Chairperson Prof Zengguang Xu) on 5 November 2021.Patients were consented by a written informed consent, which followed the Consolidated Standards of Reporting Trials (CONSORT) guidelines and was conducted in accordance with the Helsinki Declaration-2013. Consent for publicationNot applicable. Competing interestsDr. Huafeng Wei is the inventor of the WEI Nasal Jet Tube (WEI NASAL JET or WNJ), which was used to generate SJOV in this study. Other authors have no conflict of interest. Competing interests Dr. Huafeng Wei is the inventor of the WEI Nasal Jet Tube (WEI NASAL JET or WNJ), which was used to generate SJOV in this study. Other authors have no conflict of interest."

Evidence found in paper:

"Funding Shanghai East Hospital Affiliated to Tongji University Scientific Research Foundation (Grant no. DFRC2021008); Shanghai Association of Chinese Integrative Medicine Research Foundation (Grant no. MT23-2)."

Evidence found in paper:

"This clinical study was approved by the Institutional Review Board and Ethics Committee of Affiliated East Hospital of Tongji University (2021, No.097), Shanghai, China (Chairperson Prof Zengguang Xu) on 5 November 2021, and was registered at chictr.org.cn (ChiCTR2100053532, https://www.chictr.org.cn/showprojEN.html?proj=139528, Principal investigator: Zhonghua Ji, Date of registration: 2021.11.24). The clinical trial was registered prior to patient enrollment. The written informed consent was obtained from all subjects participating in the trial. This study followed the Consolidated Standards of Reporting Trials (CONSORT) guidelines and was conducted in accordance with the Helsinki Declaration-2013."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025